final program.qxd - Parallels Plesk Panel

PP 3.2
Is Age a Complicating Factor for Patients with Persistent Low Level Viremia?
Boly L,Cafaro V, Dyner T
Shared Perspectives on Therapies, San Francisco, United States
Objectives
Antiretroviral (ARV) regimens have become simplified with once daily dosing and
decreased pill count. Side effects do persist for some patients and adherence remains a
complicated issue. Continuing viral replication is thought to impact future treatment
options and immunologic competence. Many patients decide to remain on their stable
ARV treatment regimen despite the presence of low level viremia. While it has been
documented that length of time on ARVs as well as nadir CD4 counts may influence side
effects, chronological age may also contribute. We evaluated a group of patients with low
level viremia and good adherence to their ARV regimens for any impact of chronological
age on the experience of adverse side effects.
Methods
A retrospective chart review was conducted of 24 patients on stable ARV treatment
regimens who had persistent low level viremia (HIV bDNA levels